产品说明
一般描述
The side-chain Acm group is stable to TFA, but can be removed with Hg(II) [1] or Ag(I) [2] to give cysteinyl peptides, or oxidatively with Tl(III) [3] or I2 [4] to generate cystinyl peptides.
The product number for this product was previously 04-12-1014.
To obtain a certificate of analysis (CoA) of a lot that begins with the letter “A”, please select the option in the right hand menu “Request a COA for Lot#s starting with A”.
联系
Replaces: 04-12-1014
分析说明
Color (visual): white to slight yellow to beige
Appearance of substance (visual): powder
Identity (IR): passes test
Enantiomeric purity: ≥ 99.5 % (a/a)
Purity (TLC(011B)): ≥ 98 %
Purity (TLC(0811)): ≥ 98 %
Assay (HPLC, area%): ≥ 99.0 % (a/a)
Solubility (25 mmole in 50 ml DMF): clearly soluble
UV/VIS (E(450 bis 600 nm)): ≤ 50 mAU
Assay (acidimetric): ≥ 96.0 %
Water (K. F.): ≤ 5.00 %
For TLC-Systems see our General Catalog
法律信息
Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
经验(实验)分子式 | C21H22N2O5S |
分子量 | 414.47 |
MDL编号 | MFCD00038769 |
产品性质
质量水平 | 200 |
产品线 | Novabiochem® |
测定 | ≥96.0% (acidimetric) ≥98% (TLC) ≥99.0% (HPLC) |
形式 | powder |
reaction suitability | reaction type: Fmoc solid-phase peptide synthesis |
manufacturer/tradename | Novabiochem® |
mp | 147-150 ℃ |
application(s) | peptide synthesis |
官能团 | Fmoc |
储存温度 | 2-30℃ |
InChI | 1S/C21H22N2O5S/c1-13(24)22-12-29-11-19(20(25)26)23-21(27)28-10-18-16-8-4-2-6-14(16)15-7-3-5-9-17(15)18/h2-9,18-19H,10-12H2,1H3,(H,22,24)(H,23,27)(H,25,26)/t19-/m0/s1 |
InChI key | CSMYOORPUGPKAP-IBGZPJMESA-N |
安全信息
象形图 | ![]() |
警示用语: | Warning |
危险声明 | H315 - H319 - H335 |
预防措施声明 | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
靶器官 | Respiratory system |
储存分类代码 | 11 - Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
Sigma-Aldrich